I am as frustrated as many here, probably more so having invested in this dead money gut-wrenching rollercoaster for well over a decade, that had I invested elsewhere could easily have increased fivefold (conservative).  Over a decade of the company being "excited", talking with BP, failed trials, "but look what we found out" and "we'll need a new trial to investigate that indication" blah blah blah.  DM sucked me in years ago when he went on TV touting "roto-rooter for the heart".  Hook, line, sinker.

DM said it right, "you may want to sit down, I'm going to talk about REVENUE", or something to that effect.  After this amount of time, revenue. Should it be a shocker!?  No.  While all those under the Resverlogix blanket warm themselves handsomely with our money while doing what they love to do, we, the long-suffering, seemingly neglected, unnoticed, "would like to ditch them but can't because we're making millions off of them" investors, speculate, ruminate, regurgitate ad nauseam.

So, where are we after 15 years?  Pretty much where we started, with a BTD in our back pockets that the markets don't give a $#!@ about, without the knowledge that BP is truly interested in this "groundbreaking technology".  You can't possibly tell me that they don't want to take, what seems at this point to be, very limited risk and at least pay RVX half of what it could potentially be worth given the coveted green light by the FDA.

We know we won't be taking door number 1 with BP under their 5-year plan, we're most likely choosing door number 2, the 3-year "oh, just missed it" sideshow with significant dilution, no-name partners, a couple of Sheikhs and some lottery winner from Thunder#$^@ Pennsylvania!!!

Dead money until the end of summer at least.  The Sheikh's money is already factored into the SP.  If by some miracle, we get a marketable therapeutic drug for Covid by the end of the year, all will be forgiven, but this ride will certainly not be forgotten.

Rant complete, for now

GLTA